Treatment After CDK4/6 Inhibitors Breastcancer.org podcast

Artwork

Fitness Podcasting Education Medicine Caroline Durham

Kandungan disediakan oleh Breastcancer.org. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Breastcancer.org atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

Breastcancer.org Podcast « »
Treatment After CDK4/6 Inhibitors

6M ago 6:34

Kongsi

MP3•Laman utama episod

Kandungan disediakan oleh Breastcancer.org. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Breastcancer.org atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

CDK4/6 inhibitors are used to treat both early-stage and advanced-stage hormone receptor-positive, HER2-negative breast cancer.

The CDK4/6 inhibitors are:

Ibrance (chemical name: palbociclib)
Kisqali (chemical name: ribociclib)
Verzenio (chemical name: abemaciclib)

At the 2023 San Antonio Breast Cancer Symposium, Dr. Stephanie Graff moderated an educational session to help people and their doctors decide on treatments after a CDK4/6 inhibitor has stopped working.

Listen to the podcast to hear Dr. Graff explain:

how the oral SERD, Orserdu (chemical name: elacestrant), might be used
how PARP inhibitors, such as Lynparza (chemical name: olaparib) or Talzenna (chemical name: talazoparib) might be used
why using a CDK4/6 inhibitor after another CDK4/6 inhibitor probably won’t be used

… continue reading

303 episod

#Fitness #Podcasting Education #Medicine #Caroline Durham

Artwork

Treatment After CDK4/6 Inhibitors

Breastcancer.org Podcast

published 6M ago

Kongsi

MP3•Laman utama episod

Kandungan disediakan oleh Breastcancer.org. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Breastcancer.org atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

CDK4/6 inhibitors are used to treat both early-stage and advanced-stage hormone receptor-positive, HER2-negative breast cancer.

The CDK4/6 inhibitors are:

Ibrance (chemical name: palbociclib)
Kisqali (chemical name: ribociclib)
Verzenio (chemical name: abemaciclib)

At the 2023 San Antonio Breast Cancer Symposium, Dr. Stephanie Graff moderated an educational session to help people and their doctors decide on treatments after a CDK4/6 inhibitor has stopped working.

Listen to the podcast to hear Dr. Graff explain:

how the oral SERD, Orserdu (chemical name: elacestrant), might be used
how PARP inhibitors, such as Lynparza (chemical name: olaparib) or Talzenna (chemical name: talazoparib) might be used
why using a CDK4/6 inhibitor after another CDK4/6 inhibitor probably won’t be used

… continue reading

303 episod

#Fitness #Podcasting Education #Medicine #Caroline Durham

Semua episod

×

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

Dengarkan lebih 500+ topik

Panduan Rujukan Pantas

Podcast Teratas

Bantuan/Soalan Lazim | Naik taraf | Advertise

Seni|Perniagaan|Komedi|Ekonomi|Hiburan|Berita|Politik|Agama

Sains|Bolasepak|Sukan|Bercerita|Teknologi|True Crime

Hak Cipta 2024 | Peta Laman | Dasar Privasi | Syarat Perkhidmatan | | hak cipta